skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. GUD: Your thoughts on GUD going forward in light of [Knight Therapeutics Inc.]
You can view 2 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Your thoughts on GUD going forward in light of:

07:20 AM EDT, 03/24/2025 (MT Newswires) -- Knight Therapeutics (GUD.TO) overnight Sunday said G252 Capital has disposed of 2.5 million of its shares at $6.30 each, and no longer holds over 10% of Knight's outstanding shares.

G2S2 now owns 7.54 million Knight shares, for a 7.6% stake.

Does this limit upside of the stock price?
Asked by Michael on March 25, 2025
5i Research Answer:

Not necessarily, but investors could fear that G252 will keep selling its remaining shares, and thus this might be viewed as an 'overhang' of shares for a period of time. The fund will no longer have to report sales, so we would watch trading volume here for signs that it is still exiting. But if fundamentals are good the stock should be able to absorb some selling over the course of two to three months, we would expect.